ID: MRFR/Pharma/2938-HCR | 200 Pages | Author: Kinjoll Dey | March 2024
FIGURE 1 Global Antidiuretic Drugs Market by region, 2016 (%)
Key Players in the Global Antidiuretic drugs Market Some of the key players in this market are Par Sterile Products, LLC (U.S.), ADH Health (U.S.), Azevan Pharmaceuticals, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Otsuka Holdings Co. Ltd (Japan), Taj Pharmaceuticals Limited (India) and ALLERGAN (U.S.). Segments The global antidiuretic drugs market is segmented on the basis of types, which includes vasopressin, desmopressin, oxytocin, and others. Other types of antidiuretic drugs are argipressin, lypressin, ornipressin and terlipressin. On the basis of indication, the market is segmented into diabetes insipidus, hemophilia, hypertension, and others. Diabetes insipidus is further sub-segmented into central diabetes insipidus, nephrogenic diabetes insipidus, dipsogenic diabetes insipidus and gestational diabetes insipidus. Other indications are polyuria, polydipsia and enuresis. On the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies, and others. Research Methodology Regional Analysis of the Global Antidiuretic drugs Market
The American region accounted for the largest share of the global market due to increasing prevalence of diabetes insipidus, and rising demand for new drugs for the treatment of diabetes insipidus. The rate of diabetes insipidus is much higher in America than the rest of the world. According to the Diabetes Insipidus Organization, in the U.S., 1 in 6,666 American may develop diabetes insipidus. According to International Diabetes Federation, in 2016, it was estimated that 420 million adult population was suffering from diabetes which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040.
Europe is the second largest market that holds a noticeable share of the global antidiuretic drugs market. Diabetes insipidus is a common postoperative complication among children who have undergone transsphenoidal craniotomy.
In Asia Pacific, rising awareness about diabetes insipidus, huge geriatric population suffering from diabetes insipidus and increase in the risk of developing diabetes insipidus after surgery is driving the market growth. Furthermore, rising awareness about the use of antidiuretic drugs for the treatment of diabetes insipidus also propels the market growth. Middle East and Africa show steady growth in the antidiuretic drugs market. The report on the global antidiuretic drugs market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions Intended Audience
Report Attribute/Metric | Details |
Market Size | USD 621.2 Million |
CAGR | 11.5% |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Historical Data | 2020 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, Indication, End Users |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Par Sterile Products, LLC (U.S.), ADH Health (U.S.), Azevan Pharmaceuticals, Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Otsuka Holdings Co. Ltd (Japan), Taj Pharmaceuticals Limited (India) and ALLERGAN (U.S.) |
Key Market Opportunities | The American region accounted for the largest share of the global market due to increasing prevalence of diabetes insipidus, and rising demand for new drugs for the treatment of diabetes insipidus. In Asia Pacific, rising awareness about diabetes insipidus, huge geriatric population suffering from diabetes insipidus and increase in the risk of developing diabetes insipidus after surgery is driving the market growth |
Key Market Drivers | Rising prevalence of diabetes and other chronic disease such as cardiovascular diseases Growing use of antidiuretic drugs for the treatment of hemophilia Huge patient pool with hypertension |
The predicted CAGR is 11.5% for the forecast period of 2022-2030.
Antidiuretic Drugs Market valuation would be USD 621.2 Million by 2030.
The companies are ADH Health (U.S.), Par Sterile Products, LLC (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Azevan Pharmaceuticals, Inc. (U.S.), Taj Pharmaceuticals Limited (India), Otsuka Holdings Co. Ltd (Japan), and ALLERGAN (U.S.).
What are the types included in the Antidiuretic Drugs Market?
The indications discussed are hypertension, hemophilia, diabetes insipidus, and others.
Key Questions Answered
Why Choose Market Research Future?